Scientific Due Diligence Services

Once the decision is made to push forward a biotechnology transaction or initiative, Triaj can substantially reduce the risk profile of your investment and enhance returns with our in-depth due diligence and feasibility studies that bring an independent, expert review and quality assurance to your projects.

Triaj offers scientific due diligence and feasibility studies suitable for all sizes and types of transaction, including venture capital investments, mergers and acquisitions, IPOs and dispositions, joint ventures and alliances, product development projects and project funding. Our due diligence services are tailored to meet the exacting needs of the venture capital, investment banking and legal communities, and the corporate development departments of all biotech and pharmaceutical companies and governmental agencies.

The number of investment, joint venture, mergers and acquisitions, and product development projects in the biotech space is at an all time high. Despite the growth of new opportunities, there is a global shortage of scientific expertise to evaluate transactions, review technical capabilities and to manage technical information. As a result, you are often forced to rely upon scientific generalists, whose expertise is inherently limited, to provide essential scientific due diligence and advice in biotech transactions.

No commercial transaction would be undertaken without the advice of legal, accounting and financial experts. Through Triaj, it is now possible to access independent, world-class scientific expertise. Triaj's biotechnology professionals are recognized international leaders in their fields, and include experts in genetics, genomics, proteomics, molecular biology, genetic statistics, clinical epidemiology, genetic epidemiology, biostatistics, bioinfomatics, diagnostics, therapeutics, and gene mapping. Triaj's professional staff has a wealth of experience in all aspects of the biotechnology industry, providing unique and unparalleled project expertise.

Triaj's in-depth due diligence and feasibility study process is an objective, systematic and fact-driven approach tailored to precisely meet your needs. Our seasoned experts focus on the issues that matter to your business - issues than can mean the difference between an outstanding success and a complete loss of capital, time and opportunity.

Triaj's unsurpassed expertise and experience can help reduce the uncertainty and risk inherent in major corporate transactions and in implementing new technologies. We help you understand and critically assess new technologies prior to significant investment. We evaluate companies, industries, and technologies at all stages of the business life cycle. Let Triaj provide you with the scientific expertise critical to the success of your enterprise.

Profit from Triaj's experience.

In depth scientific due diligence and feasibility studies for:

• Venture capitalists, investment banks, law firms, biotech and pharmaceutical companies, governmental agencies, and other major institutions.
• Venture capital investments, mergers and acquisitions, IPOs, roll-ups, joint ventures, partnerships, divestitures, management buy-outs, product development projects and funding contracts, and special projects.
• Scientific feasibility review, market opportunity and competitor analysis, review of human capital and physical resource requirements, analysis of the project time lines, milestones, and budget, and other important data sets.

---

Back to Services